IL66317A - Preparation of 1alpha-hydroxy-vitamin d or 1alpha-hydroxy-previtamin d compounds and a certain novel 1alpha-hydroxy-previtamin d compound - Google Patents

Preparation of 1alpha-hydroxy-vitamin d or 1alpha-hydroxy-previtamin d compounds and a certain novel 1alpha-hydroxy-previtamin d compound

Info

Publication number
IL66317A
IL66317A IL66317A IL6631782A IL66317A IL 66317 A IL66317 A IL 66317A IL 66317 A IL66317 A IL 66317A IL 6631782 A IL6631782 A IL 6631782A IL 66317 A IL66317 A IL 66317A
Authority
IL
Israel
Prior art keywords
hydroxy
previtamin
1alpha
alpha
compound
Prior art date
Application number
IL66317A
Other languages
English (en)
Other versions
IL66317A0 (en
Original Assignee
Duphar Int Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duphar Int Res filed Critical Duphar Int Res
Priority to IL8018782A priority Critical patent/IL80187A/xx
Publication of IL66317A0 publication Critical patent/IL66317A0/xx
Priority to IL80187A priority patent/IL80187A0/xx
Publication of IL66317A publication Critical patent/IL66317A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL66317A 1981-07-17 1982-07-14 Preparation of 1alpha-hydroxy-vitamin d or 1alpha-hydroxy-previtamin d compounds and a certain novel 1alpha-hydroxy-previtamin d compound IL66317A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL8018782A IL80187A (en) 1981-07-17 1982-07-14 Adducts of a previtamin d or tachysterol compound with dienophiles and their preparation
IL80187A IL80187A0 (en) 1981-07-17 1986-09-29 Adducts of a previtamin d or tachysterol compound with dienophiles and their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL8103393 1981-07-17

Publications (2)

Publication Number Publication Date
IL66317A0 IL66317A0 (en) 1982-11-30
IL66317A true IL66317A (en) 1987-07-31

Family

ID=19837798

Family Applications (1)

Application Number Title Priority Date Filing Date
IL66317A IL66317A (en) 1981-07-17 1982-07-14 Preparation of 1alpha-hydroxy-vitamin d or 1alpha-hydroxy-previtamin d compounds and a certain novel 1alpha-hydroxy-previtamin d compound

Country Status (9)

Country Link
US (1) US4539153A (fr)
EP (1) EP0070588B1 (fr)
JP (3) JPS5823660A (fr)
AT (1) ATE19623T1 (fr)
CA (1) CA1327977C (fr)
DE (1) DE3270978D1 (fr)
DK (1) DK172151B1 (fr)
ES (1) ES513950A0 (fr)
IL (1) IL66317A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0402982B1 (fr) * 1989-06-15 1994-01-05 Duphar International Research B.V Adduct-aldéhyde et son utilisation pour la préparation de dérivés de vitamine D
CH681152A5 (de) * 1991-06-04 1993-01-29 Marigen S.A. Neue biotenside und antitumorale ester und phosphatide mit vitamin-d- und vitamin-e-verbindungen, ihre herstellung und aufarbeitung zu spontan dispergierbaren konzentraten.
ES2170069T3 (es) * 1992-06-22 2002-08-01 Bone Care Int Inc 1-alfa-hidroxiprevitamina d para administracion oral.
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
IN188477B (fr) * 1998-06-23 2002-09-28 Hoffmann La Roche
CA2481909C (fr) * 2002-04-11 2013-07-02 Instytut Farmaceutyczny Preparation d'analogues alkyl-24 de cholecalciferol
WO2005067673A2 (fr) * 2004-01-06 2005-07-28 The University Of Tennessee Research Foundation Procede enzymatique permettant de produire du 7-dehydropregnenolone, des composes de type vitamine d3 et des derives de ceux-ci
TW200714580A (en) * 2005-10-14 2007-04-16 Formosa Lab Inc Process for preparing vitamin D analogs

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901928A (en) * 1973-01-10 1975-08-26 Robert Henry Hesse 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds
US3993675A (en) * 1975-02-24 1976-11-23 Hoffmann-La Roche Inc. Process for the preparation of 1α,25-dihydroxycholecalciferol
US4069321A (en) * 1975-10-14 1978-01-17 Merck & Co., Inc. Blocked cholecalciferol and dihydrotachysterol 3 derivatives
US4022768A (en) * 1976-02-12 1977-05-10 Wisconsin Alumni Research Foundation Process for preparation of 1α,25-dihydroxycholecalciferol
US4110446A (en) * 1977-07-14 1978-08-29 Wisconsin Alumni Research Foundation Method of treating milk fever in dairy cattle with 1,25-dihydroxycholecalciferol
US4202829A (en) * 1978-01-05 1980-05-13 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4195027A (en) * 1978-01-16 1980-03-25 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4206131A (en) * 1978-06-19 1980-06-03 The Upjohn Company Compounds and process
JPS557215A (en) * 1978-06-30 1980-01-19 Teijin Ltd Preparation of active vitamin d3 or its oh-protected derivative and/or its corresponding previtamin d3 or its oh-protected derivative
PH16989A (en) * 1978-11-07 1984-05-04 Res Inst Medicine Chem Process for the preparation of 1-hydroxylated vitamin d compounds
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials

Also Published As

Publication number Publication date
CA1327977C (fr) 1994-03-22
DK172151B1 (da) 1997-12-01
DE3270978D1 (en) 1986-06-12
IL66317A0 (en) 1982-11-30
JPS63107964A (ja) 1988-05-12
US4539153A (en) 1985-09-03
DK315782A (da) 1983-01-18
ATE19623T1 (de) 1986-05-15
JPH037664B2 (fr) 1991-02-04
JPH0420431B2 (fr) 1992-04-02
JPH0339058B2 (fr) 1991-06-12
JPS6399053A (ja) 1988-04-30
ES8308847A1 (es) 1983-10-01
JPS5823660A (ja) 1983-02-12
EP0070588B1 (fr) 1986-05-07
ES513950A0 (es) 1983-10-01
EP0070588A1 (fr) 1983-01-26

Similar Documents

Publication Publication Date Title
ES8404993A1 (es) Procedimiento para preparar derivados de piridina
AU1920683A (en) Diazabicyclo-(3.3.1)nonanes
PT77443A (en) Process for the preparation of pharmaceutical composition comprehending calcitonine
DE3278400D1 (en) Process for the preparation of 1-hydroxylated vitamin d compounds
AU560689B2 (en) Method of protecting bacteria from bacteriophage
DE3270978D1 (en) Method of preparing 1-alpha-hydroxyvitamin d and 1-alpha-hydroxy-previtamin d compounds, and adduct of a previtamin d or tachysterol compound with a suitable dienophile
AU562823B2 (en) Process for preparation of synthesis gas
AU557042B2 (en) Crystallographic modification of pigment red 53:1
ES8706601A1 (es) Un procedimiento para preparar haluros de gamma haloacetilo.
IL75357A (en) Primycin components,process for the separation of the antibiotic complex and antibiotic pharmaceutical compositions containing them
DE3266922D1 (en) At position 17 esterified and at position 21 thio-esterified steroids, process for their preparation and their utilisation as pharmaceutical preparations
WO1987005906A3 (fr) Groupes protecteurs pour synthese organique
EP0507234A3 (en) Method for cell isolation, isolated cells (dsm 6314 and dsm 618) and use of these isolated cells for preparing polysaccharids
DE3274251D1 (en) Process for the preparation of nitrocellulose compositions
AU6511890A (en) Method for the preparation of an immunizing composition
JPS55164672A (en) Azetidine derivative and its preparation
ZA91758B (en) Process for the preparation of o-substituted hydroxylamines
JPS5268196A (en) Bicyclomycin derivatives
DE3366937D1 (en) Process for the preparation of polyisoprene
EP0041919A3 (en) Process for the preparation of amino-fluor-s-triazine dyestuffs
EP0103817A3 (en) Process for the preparation of 2-chloro-benzothiazole
DE3361771D1 (en) Method for the preparation of pure 2-chloro-6-alkoxy-3-nitro-pyridines
JPS5738799A (en) 25-hydroxy-3,24-dioxocholesta-1,4,6-trienes and their preparations
SU694278A1 (ru) Оснастка дл нанесени облицовки на посто нные формы
GR81357B (fr)

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired